Published in Aliment Pharmacol Ther on August 01, 1996
Ranitidine bismuth citrate with clarithromycin for the treatment of duodenal ulcer. Gut (1997) 0.90
Helicobacter pylori. Postgrad Med J (2000) 0.75
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature (2001) 33.12
Is measles vaccination a risk factor for inflammatory bowel disease? Lancet (1995) 6.75
Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction. Lancet (1989) 5.70
Identification of Campylobacter pyloridis isolates by restriction endonuclease DNA analysis. J Clin Microbiol (1986) 5.15
Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet (1993) 4.55
One week eradication regimen for Helicobacter pylori. Lancet (1991) 4.50
A simple clinical colitis activity index. Gut (1998) 4.35
Effect of cimetidine on 24-hour intragastric acidity in normal subjects. Gut (1976) 3.75
Cost effectiveness of screening for and eradication of Helicobacter pylori in management of dyspeptic patients under 45 years of age. BMJ (1996) 3.33
Prosthetic valve endocarditis. Analysis of 38 cases. Circulation (1973) 3.29
Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity. Gut (1984) 3.18
Eradication of Helicobacter pylori using one-week triple therapies combining omeprazole with two antimicrobials: the MACH I Study. Helicobacter (1996) 3.13
Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bileduct stones. Lancet (1997) 3.12
Ranitidine and cimetidine in prevention of duodenal ulcer relapse. A double-blind, randomised, multicentre, comparative trial. Lancet (1984) 3.11
Mortality in Barrett's esophagus: three decades of experience at a single center. Endoscopy (2012) 2.67
24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients. Lancet (1975) 2.67
Genetics versus environment in inflammatory bowel disease: results of a British twin study. BMJ (1996) 2.64
The MACH2 study: role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies. Gastroenterology (1999) 2.64
Survival analysis in percutaneous endoscopic gastrostomy feeding: a worse outcome in patients with dementia. Am J Gastroenterol (2000) 2.60
Genotypical variation of Campylobacter pylori from gastric mucosa. J Clin Microbiol (1990) 2.55
Long-term follow-up after endoscopic sphincterotomy for bile duct stones in patients younger than 60 years of age. Gastrointest Endosc (1996) 2.54
A role for the macaque anterior cingulate gyrus in social valuation. Science (2006) 2.41
Paramyxovirus infections in childhood and subsequent inflammatory bowel disease. Gastroenterology (1999) 2.39
Regulation of gastric epithelial cell growth by Helicobacter pylori: offdence for a major role of apoptosis. Gastroenterology (1997) 2.39
Separate value comparison and learning mechanisms in macaque medial and lateral orbitofrontal cortex. Proc Natl Acad Sci U S A (2010) 2.35
Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol (1997) 2.32
Effect of daily oral omeprazole on 24 hour intragastric acidity. Br Med J (Clin Res Ed) (1983) 2.30
Intraaortic balloon pumping for cardiac support: trends in practice and outcome, 1968 to 1995. J Thorac Cardiovasc Surg (1997) 2.27
Treatment of Helicobacter pylori infection: a review of the world literature. Helicobacter (1996) 2.26
Refractory duodenal ulcer. Gut (1984) 2.25
Detection of herpesvirus DNA in the large intestine of patients with ulcerative colitis and Crohn's disease using the nested polymerase chain reaction. J Med Virol (1992) 2.22
Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole. Gut (1995) 2.20
Heterogeneous Helicobacter pylori isolates from members of a family with a history of peptic ulcer disease. Gastroenterology (1996) 2.17
Increased mast cells in the irritable bowel syndrome. Neurogastroenterol Motil (2000) 2.16
A systematic review of Helicobacter pylori eradication therapy--the impact of antimicrobial resistance on eradication rates. Aliment Pharmacol Ther (1999) 2.14
Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut (1990) 2.13
Treatment of bile duct lesions after laparoscopic cholecystectomy. Gut (1996) 2.12
Self-expanding metal stents in benign biliary strictures due to chronic pancreatitis. Endoscopy (2004) 2.08
[Obstructive jaundice after surgery of the biliary tract, a benign stricture or not?]. Ned Tijdschr Geneeskd (2004) 2.05
[Changed diagnosis and treatment of hepatocellular carcinoma]. Ned Tijdschr Geneeskd (1996) 2.04
Tegaserod, a 5-HT(4) receptor partial agonist, relieves symptoms in irritable bowel syndrome patients with abdominal pain, bloating and constipation. Aliment Pharmacol Ther (2001) 2.04
One week triple therapy for Helicobacter pylori: a multicentre comparative study. Lansoprazole Helicobacter Study Group. Gut (1997) 2.00
Transmucosal penetration of bismuth particles in the human stomach. Gastroenterology (1992) 2.00
Model of medical treatment for duodenal ulcer. Lancet (1981) 1.98
Evaluation of the polymerase chain reaction for detecting the urease C gene of Helicobacter pylori in gastric biopsy samples and dental plaque. J Med Microbiol (1993) 1.94
Clinical and hemodynamic results of intraaortic balloon pumping and surgery for cardiogenic shock. Circulation (1972) 1.94
Aortic dissection. N Engl J Med (1987) 1.94
Incidence and clinical findings of benign, inflammatory disease in patients resected for presumed pancreatic head cancer. Gastrointest Endosc (1997) 1.88
Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia. Gut (1997) 1.88
24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine. Gut (1977) 1.87
Emergency admissions for upper gastrointestinal disease and their relation to NSAID use. Aliment Pharmacol Ther (1997) 1.86
Outcome of palliative biliary and gastric bypass surgery for pancreatic head carcinoma in 126 patients. Br J Surg (1997) 1.84
Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis (2000) 1.83
Biliary endoprostheses in elderly patients with endoscopically irretrievable common bile duct stones: report on 117 patients. Gastrointest Endosc (1995) 1.82
Inhibition of food-stimulated gastric acid secretion by cimetidine. Gut (1976) 1.82
DNA patterns of Helicobacter pylori isolated from gastric antrum, body, and duodenum. Gastroenterology (1992) 1.80
A survey of dyspepsia in Great Britain. Aliment Pharmacol Ther (1996) 1.79
Evidence of persistent measles virus infection in Crohn's disease. J Med Virol (1993) 1.76
Eradication of Helicobacter pylori with clarithromycin and omeprazole. Gut (1994) 1.75
Intraoperative aortic dissection. Ann Thorac Surg (1992) 1.74
Surgical coronary revascularization in survivors of prehospital cardiac arrest: its effect on inducible ventricular arrhythmias and long-term survival. J Am Coll Cardiol (1990) 1.73
Impaired quality of life 5 years after bile duct injury during laparoscopic cholecystectomy: a prospective analysis. Ann Surg (2001) 1.71
Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology (1995) 1.69
Acute upper gastrointestinal bleeding in the Amsterdam area: incidence, diagnosis, and clinical outcome. Am J Gastroenterol (1997) 1.69
Does treatment with cimetidine extended beyond initial healing of duodenal ulcer reduce the subsequent relapse rate? Br Med J (Clin Res Ed) (1982) 1.69
Serum -glytamyl transpeptidase activity in liver disease. Gut (1972) 1.69
Macrophage heterogeneity in normal colonic mucosa and in inflammatory bowel disease. Gut (1988) 1.67
Changes in facial movement after maxillary osteotomies. J Oral Maxillofac Surg (1997) 1.66
The absorption of bismuth from oral doses of tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.65
Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther (1987) 1.62
Incidence of benign lesions in patients resected for suspicious hilar obstruction. Br J Surg (2001) 1.62
Late prosthetic valve endocarditis: clinical features influencing therapy. Am J Med (1978) 1.62
A validated dyspepsia symptom score. Ital J Gastroenterol Hepatol (1997) 1.61
Intragastric bacterial activity and nitrosation before, during, and after treatment with omeprazole. Br Med J (Clin Res Ed) (1984) 1.61
What an endoscopist should know about immunoglobulin-G4-associated disease of the pancreas and biliary tree. Endoscopy (2011) 1.61
Patient knowledge and educational needs in irritable bowel syndrome. Eur J Gastroenterol Hepatol (2000) 1.60
Cephalothin prophylaxis in cardiac valve surgery. A prospective, double-blind comparison of two-day and six-day regimens. J Thorac Cardiovasc Surg (1977) 1.60
Analysis of cDNA microarray images. Brief Bioinform (2001) 1.60
Helicobacter pylori and HIV infection. Lancet (1990) 1.59
Benign biliary strictures. Surgery or endoscopy? Ann Surg (1993) 1.59
Is proximal demarcation of ulcerative colitis determined by the territory of the inferior mesenteric artery? Lancet (1995) 1.58
New normalization methods for cDNA microarray data. Bioinformatics (2003) 1.56
Clarithromycin and omeprazole for Helicobacter pylori. Lancet (1992) 1.54
Delayed gastric emptying after standard pancreaticoduodenectomy versus pylorus-preserving pancreaticoduodenectomy: an analysis of 200 consecutive patients. J Am Coll Surg (1997) 1.52
Bismuth accumulates in the body during treatment with tripotassium dicitrato bismuthate. Aliment Pharmacol Ther (1989) 1.52
Follow-up study of individuals with untreated Campylobacter pylori-associated gastritis and of noninfected persons with non-ulcer dyspepsia. J Infect Dis (1988) 1.52
Bile duct injury after laparoscopic cholecystectomy: the value of endoscopic retrograde cholangiopancreatography. Gut (1993) 1.52
Healing of gastric ulcer during treatment with cimetidine. Lancet (1976) 1.52
Risk of reoperative valve replacement for failed mitral and aortic bioprostheses. Ann Thorac Surg (1998) 1.52
The effect of ranitidine, cimetidine or famotidine on low-dose post-prandial alcohol absorption. Aliment Pharmacol Ther (1991) 1.51
Helicobacter pylori and gastroduodenal secretory function. Gastroenterology (1996) 1.50
A randomized trial of endoscopic balloon dilation and endoscopic sphincterotomy for removal of bile duct stones in patients with a prior Billroth II gastrectomy. Gastrointest Endosc (2001) 1.49
Validation of the Rockall risk scoring system in upper gastrointestinal bleeding. Gut (1999) 1.49
Bile acid malabsorption in persistent diarrhoea. J R Coll Physicians Lond (2001) 1.49
Surgery for post-myocardial infarct ventricular septal defect. Ann Surg (1977) 1.49